Clinical Trials on Secondary-progressive Multiple Sclerosis in Poland
Total 342 results
-
Rebecca SpainCompletedComparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple SclerosisProgressive Multiple Sclerosis | Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
AB ScienceCompletedMultiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Relapse FreePoland, Spain, Bulgaria, France, Germany, Greece, Romania
-
Institute of Psychiatry and Neurology, WarsawPoznan University of Medical Sciences; Nalecz Institute of Biocybernetics and... and other collaboratorsRecruitingMultiple Sclerosis | Multiple Sclerosis, Secondary ProgressivePoland
-
Opexa Therapeutics, Inc.CompletedMultiple Sclerosis | Autoimmune Diseases of the Nervous System | Disease Progression | Secondary Progressive Multiple Sclerosis | Brain AtrophyUnited States, Canada
-
BiogenTerminatedMultiple Sclerosis, Secondary ProgressiveUnited States, Poland, Belgium, Slovakia, Czech Republic, Netherlands
-
National Institute of Allergy and Infectious Diseases...Novartis Pharmaceuticals; Autoimmunity Centers of ExcellenceCompletedSecondary Progressive Multiple SclerosisUnited States
-
MediciNovaNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes... and other collaboratorsCompletedSafety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple SclerosisMultiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
BiogenTerminatedSecondary Progressive Multiple SclerosisUnited States, Finland, Italy, Spain, Canada, France, Israel, Sweden, Netherlands, Belgium, Poland, United Kingdom, Czechia, Denmark, Russian Federation, Germany, Ireland
-
SanofiActive, not recruitingSecondary Progressive Multiple SclerosisUnited States, Argentina, Belgium, Canada, Czechia, France, Germany, Greece, India, Israel, Netherlands, Norway, Portugal, Turkey, United Kingdom, Japan, Austria, Bulgaria, China, Denmark, Finland, Italy, Lithuania, Poland, Romania, Russian... and more
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN); Blood...RecruitingRelapsing Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedSecondary Progressive Multiple SclerosisChina, Germany, United States, Romania, Italy, Austria, Belgium, Czechia, Spain, Australia, Canada, France, Israel, Switzerland, Bulgaria, Hungary, Netherlands, United Kingdom, Estonia, Latvia, Lithuania, Russian Federation, Turkey, J... and more
-
AB ScienceRecruitingProgressive Multiple SclerosisSpain, Sweden, France, Greece, Italy, Poland, Russian Federation, Ukraine
-
Hoffmann-La RocheActive, not recruitingProgressive Multiple Sclerosis (PMS)United States, Canada, Brazil, France, Netherlands, Ireland, Germany, Italy, Poland, Russian Federation, Spain, Colombia, Morocco, Hungary, Denmark, Lebanon, Mexico, Costa Rica, Bosnia and Herzegovina, Czechia, Egypt, Guatemala, Panama and more
-
Hoffmann-La RocheActive, not recruitingRelapsing Multiple Sclerosis | Primary Progressive Multiple SclerosisSpain, United States, Italy, Poland, Turkey, New Zealand, Czechia, Brazil
-
VA Office of Research and DevelopmentActive, not recruitingMultiple SclerosisUnited States, Canada
-
Genentech, Inc.No longer availableMultiple SclerosisUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedPrimary Progressive Multiple SclerosisUnited States, Canada, Germany, Italy, Netherlands, Poland, Russian Federation, Spain, Ukraine, United Kingdom
-
MedDay Pharmaceuticals SATerminatedMultiple SclerosisUnited States, Spain, Canada, Australia, United Kingdom, Belgium, Turkey, Czechia, Poland, Italy, Hungary, Germany, Sweden
-
Immunic AGActive, not recruitingMultiple SclerosisUnited States, Germany, Netherlands, Bulgaria, Serbia, Canada, Czechia, Moldova, Republic of, North Macedonia, Poland, Romania, Ukraine
-
Novartis PharmaceuticalsTerminatedPrimary Progressive Multiple SclerosisUnited States, Belgium, Poland, Germany, Hungary, Turkey, Spain, Australia, Canada, Czechia, Switzerland, United Kingdom, Netherlands, France, Italy, Denmark, Finland, Sweden
-
Hoffmann-La RocheActive, not recruitingMultiple Sclerosis, Primary ProgressiveUnited States, Canada, Australia, United Kingdom, Hungary, Bulgaria, Puerto Rico, Poland, Argentina, Brazil, Germany, Greece, Italy, Peru, Portugal, Russian Federation, Spain, Turkey, Ukraine, Israel, France, Switzerland, Colombia, Me... and more
-
Artielle ImmunoTherapeuticsUnknownMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-RemittingUnited States
-
VA Office of Research and DevelopmentOregon Health and Science UniversityCompletedMultiple Sclerosis, Chronic ProgressiveUnited States
-
Hoffmann-La RocheCompletedMultiple Sclerosis, Primary ProgressiveUnited States, Canada, Australia, Hungary, Brazil, Finland, Italy, Germany, Romania, Lithuania, France, Greece, Peru, Portugal, Spain, Switzerland, Bulgaria, Ukraine, Israel, Poland, Austria, New Zealand, Netherlands, Belgium, Mexico, United... and more
-
SanofiRecruitingPrimary Progressive Multiple SclerosisSpain, Italy, Turkey, India, Israel, Bulgaria, Mexico, Greece, Portugal, United States, Argentina, Australia, Austria, Belarus, Belgium, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark, Estonia, France, Georgia, Germany, Hungary, Japan and more
-
Hoffmann-La RocheRecruitingMultiple Sclerosis, Primary ProgressiveCanada, United States, Spain, Croatia, Serbia, Portugal, France, Tunisia, Mexico, Poland, Russian Federation, Australia, Belgium, Italy, United Kingdom, Ukraine, Bulgaria, Colombia, Georgia, Germany, Romania, New Zealand, Lebanon, Aus... and more
-
Hoffmann-La RocheActive, not recruitingMultiple SclerosisBelgium, United Kingdom, Netherlands, Serbia, Poland, Slovakia, Bulgaria, Turkey, Brazil, Italy, Russian Federation, Spain, Austria, Colombia, Romania, Kuwait, Chile, Dominican Republic, Egypt, Montenegro, Panama, Paraguay, Portugal, ... and more
-
Hoffmann-La RocheActive, not recruitingMultiple SclerosisUnited States, Brazil, Poland, United Kingdom, Turkey, Bulgaria, Belgium, Canada, Denmark, France, Germany, Greece, Hungary, Italy, Peru, Portugal, Russian Federation, Spain, Switzerland, Ukraine, Mexico, Argentina
-
CelltrionRecruitingRelapsing-remitting Multiple SclerosisPoland
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedRelapsing Multiple SclerosisUnited States, Bulgaria, Croatia, Czechia, Estonia, Georgia, Germany, Israel, Italy, Lithuania, North Macedonia, Poland, Romania, Russian Federation, Slovakia, South Africa, Spain, Ukraine
-
Providence Multiple Sclerosis CenterBiogenCompletedClinically Isolated Syndrome | Relapsing-remitting Multiple SclerosisUnited States
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingBelgium, Germany, Russian Federation, Spain, Poland
-
Galapagos NVTerminatedClinically Isolated Syndrome | Acute Exacerbation of Remitting Relapsing Multiple SclerosisBelgium, Poland, Germany
-
Eli Lilly and CompanyBioMS Technology Corp.CompletedRelapsing Remitting Multiple SclerosisSerbia, Bulgaria, Poland, Russian Federation, Slovakia, Ukraine
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedRelapsing Multiple SclerosisUnited States, Austria, Bulgaria, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Israel, Italy, Lithuania, Netherlands, Poland, Romania, Russian Federation, Serbia, Spain, Sweden, Turkey, Ukraine, United Kingdom
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisBelgium, Bulgaria, Canada, Croatia, Czech Republic, Finland, Germany, Hungary, Italy, Lithuania, Poland, Russian Federation, Serbia, Spain, Turkey, Ukraine, United Kingdom
-
Providence Health & ServicesCompletedRelapsing Remitting Multiple SclerosisUnited States
-
BiogenElan PharmaceuticalsCompletedRelapsing Remitting Multiple Sclerosis (RRMS)Belgium, Mexico, Poland, Romania, Saudi Arabia, Ukraine
-
Merck KGaA, Darmstadt, GermanyCompletedRelapsing Multiple Sclerosis (RMS)Germany, Poland
-
Immunic AGActive, not recruitingRelapsing-Remitting Multiple Sclerosis (RRMS)Poland, Bulgaria, Romania, Ukraine
-
Genzyme, a Sanofi CompanyTerminatedRelapsing-remitting Multiple SclerosisRussian Federation, United States, Canada, Poland
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisCroatia, Bulgaria, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Lithuania, Poland, Belgium, Hungary, Serbia, Finland, Ukraine, Switzerland, Canada, Turkey
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisPoland, Hungary, United States, Czech Republic
-
Hoffmann-La RocheActive, not recruitingMultiple SclerosisUnited States, Italy, Poland
-
Providence Health & ServicesGenentech, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States
-
Polpharma Biologics S.A.CompletedRelapsing-Remitting Multiple Sclerosis (RRMS)Belarus, Ukraine, Georgia, Croatia, Moldova, Republic of, Poland, Serbia
-
Nuron Biotech Inc.UnknownRelapsing Remitting Multiple SclerosisPoland, Spain, Belarus, Bulgaria, Serbia, Ukraine, Russian Federation, Hungary, Italy, Croatia, Georgia, Lebanon
-
Genzyme, a Sanofi CompanyTerminatedRelapsing-remitting Multiple SclerosisSweden, Poland, Russian Federation, United States, Canada
-
Novartis PharmaceuticalsCompletedRelapsing Multiple ScelrosisUnited States, Austria, Belgium, Croatia, Germany, Taiwan, Canada, Czechia, Spain, Argentina, Australia, Peru, South Africa, United Kingdom, Bulgaria, Latvia, Lithuania, Russian Federation, India, Portugal, Italy, Turkey, Finland, France and more